Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)

Clinical trial NCT07165847 · RECRUITING

Trial details

NCT number: NCT07165847
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Immunotherapy Gastric Cancer (GC)Radiotherapy Neoadjuvant Therapy Neoadjuvant Chemoimmunotherapy

Start date: 2025-07-23
Primary completion: 2028-09-23
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.